Business Context and Reporting Period
Company: Nephros, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 8, 2021
Reporting Period: Preliminary results for the second quarter of 2021.
This filing serves to disclose the issuance of a press release containing preliminary financial results for Q2 2021. The detailed financial data is contained in Exhibit 99.1 (Press Release) and is not embedded directly in the text of this 8-K form.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being disclosed in the attached press release (Exhibit 99.1) but are not present in the provided document content.
Material Changes
No material changes or comparative financial data versus prior periods are detailed in the text of this filing. The document solely announces the availability of the preliminary Q2 2021 results.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of a press release by the Company on July 8, 2021.
Legal Status of Information: The press release and the information within Item 2.02 are "furnished" rather than "filed" under the Securities Exchange Act of 1934. Consequently, they are not subject to liability under Section 18 of the Exchange Act and are not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 8, 2021) for actual Q2 2021 financial figures.
- Verify the specific revenue, net loss, and cash position numbers in the press release, as they are absent from the 8-K text.
- Confirm whether the preliminary results include any updated full-year guidance or operational milestones.
- Note that the furnished information is not legally "filed" for liability purposes under Section 18 of the Exchange Act.